Mixed endothelial tumors of the colon and rectum are rare, poorly understood entities that include a heterogeneous range of tumors with multiple combinations leading to tumors with acute malignant potential. high, medium or low. In the following article, we will learn more about the pathology of these tumors.

Mixed tumors of the colon and rectum, consisting of a combination of epithelial and endocrine factors with both benign and malignant potential, are rare neoplasms. These tumors can occur anywhere in the gastrointestinal tract and are often diagnosed incidentally.

Mixed endothelial tumors of the colon and rectum are a rare entity, noted with unique histology and clinical behavior. The exact pathogenesis of these tumors remains unclear as they are often characterized by histological heterogeneity, making it impossible to make an accurate diagnosis.

The term “mixed endocrine neoplasm” (MANEC) was coined by the World Health Organization in 2010 to refer to a type of cancer with a dual differentiation between adenocarcinoma and neuroendocrine carcinoma, each components represent at least 30% of tumors. In the following article, we will learn about the prognosis of this type of tumor.

The term “mixed endocrine neoplasm” (MANEC) was coined by the World Health Organization in 2010 to refer to a type of cancer with a dual differentiation between adenocarcinoma and neuroendocrine carcinoma, each components represent at least 30% of tumors. Prior to 2010, this tumor was reported as a mixed tumor.